Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022)
Although LATAM's participation in global oncology trials has increased, it remains geographically concentrated and demographically under-reported. Structural and policy efforts are needed to improve trial equity and align research with regional cancer burdens.
Authors
- Deborah B. Doroshow (ORCID: https://orcid.org/0000-0002-2221-9818)
- Rocío Fuente (ORCID: https://orcid.org/0000-0002-2311-2836)
- Alexander B. Karol (ORCID: https://orcid.org/0000-0001-8277-9932)
- Anneliese Markus (ORCID: https://orcid.org/0000-0002-0677-8556)
- Himanshu Joshi (ORCID: https://orcid.org/0000-0003-0272-0733)
- Anna Argulian
- Reo Omori
- Y. Fujiwara
- Matthew D. Galsky
Institutions
- Tokyo Medical and Dental University (JP)
- Roswell Park Comprehensive Cancer Center (US)
- Universidad de San Martín de Porres (PE)
- Osaka City General Hospital (JP)
- Jacobs (United States) (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1200/go-25-00411
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00